Johnson & Johnson filed suit against HHS on Tuesday in federal court regarding the agency's 340B program that provides discounted drugs to hospitals and clinics that primarily serve poor and underinsured patients.

While drugmakers usually provide those discounts upfront, in August, the

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.